Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer. Reply. Burstein HJ. N Engl J Med 2021;384:1176-1177.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Burstein HJ. Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer. Reply. N Engl J Med 2021;384:1176-1177.
PMID: 33761226